Vindesine clinical trials
Vindesine is named as an intervention in 6 current clinical trials in our China, Germany, Italy, Switzerland, Austria, Czechia, Israel, France, Spain, Netherlands, Belgium, Sweden, Denmark, Norway, Australia, Ireland, Poland and Portugal registers. 5 are recruiting patients now. The most common phase is Phase 3. The sponsor with the most trials is University Hospital Muenster (1). The most-studied condition is Lymphoblastic Lymphoma, Childhood.
How Vindesine works
All drug targets →- B-cell acute lymphoblastic leukemiaPhase 3
- Hodgkins lymphomaPhase 3
- T-cell acute lymphoblastic leukemiaPhase 3
- T-lymphoblastic lymphomaPhase 3
- Acute lymphoblastic leukemiaPhase 3
- Cervical cancerPhase 3
- Diffuse large B-cell lymphomaPhase 3
- Early T cell progenitor acute lymphoblastic leukemiaPhase 3
- Lymphoblastic lymphomaPhase 3
- NeuroblastomaPhase 3
Mechanisms and diseases from ChEMBL via the Open Targets Platform (release 26.09), ChEMBL record CHEMBL238071, CC BY-SA 3.0. The Guide to Pharmacology has no record of this medicine, so its targets rest on ChEMBL alone. Trial phases are not approvals: approved uses are shown from the regulators' own records where we hold them.
Patient leaflets for Vindesine
The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.
- UKUnited Kingdom: Search MHRA ProductsPatient information leaflets and SmPCs for UK-licensed products.
- USUnited States: Search DailyMedFDA-approved labels, including patient and medication guides.
Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.
Trials by status
Trials by phase
Clinical trials of Vindesine
6 trialsRegisters list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
Vindesine across our data
Ireland · EU · USThe same active substance in our other registers, matched by its exact name. Each entry links to the register record it comes from.
Supply shortages
- EldisineEU (EMA) · Shortage ongoing · first published 23 Feb 2024
- EldisineGermany (BfArM) · Production problem · 23 Oct 2023 to 30 Mar 2027
Conditions studied with Vindesine
8 conditionsSponsors
lead sponsor per trialBy country register
A trial with sites in more than one country appears in each of those registers.
Related compounds
Questions about Vindesine trials
How many clinical trials are testing Vindesine?
6 current trials in our China, Germany, Italy, Switzerland, Austria, Czechia, Israel, France, Spain, Netherlands, Belgium, Sweden, Denmark, Norway, Australia, Ireland, Poland and Portugal registers name Vindesine (also registered as L01CA03) as a drug or biological intervention, as of the registry sync on 10 November 2026. Completed and withdrawn studies are not counted.
Are Vindesine trials recruiting patients?
Yes. 5 of the 6 trials are recruiting: 3 with sites in China, 3 with sites in Germany, 3 with sites in Italy, 3 with sites in Switzerland, 3 with sites in Austria, 3 with sites in Czechia, 3 with sites in Israel, 2 with sites in France, 2 with sites in Spain, 2 with sites in Netherlands, 2 with sites in Belgium, 2 with sites in Sweden, 2 with sites in Denmark, 2 with sites in Norway, 2 with sites in Australia, 1 with sites in Ireland, 1 with sites in Poland and 1 with sites in Portugal. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Who sponsors Vindesine clinical trials?
University Hospital Muenster (1), The First Affiliated Hospital of Soochow University (1), First Affiliated Hospital of Zhejiang University (1) and West China Hospital (1), among 6 lead sponsors in total. The number in brackets is how many trials each organisation leads.
Are there Vindesine clinical trials in Ireland?
Yes. 1 trial in our Ireland register (ClinicalTrials.gov). Some may be the same study registered in both. See the Irish clinical trials register for sites and contacts.
Is there a Vindesine shortage?
The registers we track list 2 entries for Vindesine: Eldisine (EU: shortage ongoing); 1 German notice. Shortages are product- and country-specific; check with a pharmacist.
Where does this information come from?
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Vindesine works or whether it is effective, and it is not medical advice.
How this page is built
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Vindesine works or whether it is effective. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, intervention names and synonyms, phase, overall status, lead sponsor and conditions for every trial on this page
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Vindesine (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 10 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.